Does the Enhanced Rehabilitation Programs Facilitate the Motor Recovery After Stroke?
NCT ID: NCT03230370
Last Updated: 2019-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2018-12-01
2020-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The recovery in both neurological status and motor functions will be explored.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Functional Training in Acute Stroke Inpatient Ward
NCT04488692
Changes in and Determinants of Movement Performance, Functional Status, and Health-Related Quality of Life After Stroke Rehabilitation
NCT00780533
Robotic-assisted Therapy With Bilateral Practice Improves Task and Motor Performance of the Upper Extremity for Chronic Stroke Patients
NCT03847103
Robot-Assisted Therapy in Stroke Patients
NCT00917605
Differential Effectiveness of Robotic Assisted Therapy on Upper Extremity Function in Patients With Chronic Stroke
NCT04260061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Both groups receive routine rehabilitation including daily 50 mins of physical therapy and 50 mins of occupational therapy.
The enhanced upper extremity program group receives additional daily 50 mins program focusing on training of the hemiplegic upper extremity, while the enhanced lower-extremity program group receives additional daily 50 mins program focusing on training of the hemiplegic lower extremity. The participants receive 20-day training over a 4-week period. The additional program is designed to be specific to either upper-extremity or lower-extremity. Accordingly, one group can be used as the control group of the other one.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
enhanced upper-extremity program, EUEP
Both groups receive routine rehabilitation including daily 50 mins of physical therapy and 50 mins of occupational therapy.
The EUP group receives additional daily 50 mins program focusing on training of the hemiplegic upper extremity.
The participants receive 20-day training over a 4-weekperiod. The additional program is designed to be specific to either upper-extremity or lower-extremity.
Accordingly, one group can be used as the control group of the other one.
UFT
The EUEP group receives additional daily 50 mins program focusing on training of the hemiplegic upper extremity,
enhanced lower-extremity program,ELLP)
Both groups receive routine rehabilitation including daily 50 mins of physical therapy and 50 mins of occupational therapy.
The ELP group receives additional daily 50 mins program focusing on training of the hemiplegic lower extremity.
The participants receive 20-day training over a4-weekperiod. The additional program is designed to be specific to either upper-extremity or lower-extremity.
Accordingly,one group can be used as the control group of the other one.
LFT
The ELEP group receives additional daily 50 mins program focusing on training of the hemiplegic lower extremity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
UFT
The EUEP group receives additional daily 50 mins program focusing on training of the hemiplegic upper extremity,
LFT
The ELEP group receives additional daily 50 mins program focusing on training of the hemiplegic lower extremity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age: 20-80y
3. With a hemiplegic upper extremity with Brunnstrom stage in I\~IV
4. Able to understand simple orders (1-step orders, such as "raise your hand, touch your head….)
5. Totally independent in activity of daily life before the onset of stroke
Exclusion Criteria
2. Stroke of brainstem or cerebellum
3. Had received craniotomy or ventriculoperitoneal shunting
4. Needs of orthoses in walking before the onset of stroke
5. Had had motor dysfunctions (eg, amputation, cerebral palsy, poliomyelitis or other neuromuscular diseases) before the stroke.
6. Intracranial hemorrhage caused by artereovenous malformation, aneurysm, or tumor
7. Able to walk independently for more than 50 meters.
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University WanFang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yen-Nung Lin
Director of Rehabilitation Department of Taipei Medical University WanFang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
WanFang Hospital
New Taipei City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Clark B, Whitall J, Kwakkel G, Mehrholz J, Ewings S, Burridge J. The effect of time spent in rehabilitation on activity limitation and impairment after stroke. Cochrane Database Syst Rev. 2021 Oct 25;10(10):CD012612. doi: 10.1002/14651858.CD012612.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N201705071
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.